Dr. Peterson’s Cancer Research Published

American Journal of Surgery, Volume 189, Number 5; 627-631.

American Journal of Surgery has published “Combination glutathione and anthocyanins as an alternative for skin care during external beam radiation,” in it’s May, 2005 edition. This paper reports on the outcome of double-blind placebo controlled trial of RayGel™, a product developed by Dr. Noel Peterson for the prevention of radiation burn. The study, funded by a grant from the Legacy Foundation and conducted at Legacy Good Samaritan Hospital in Portland, OR.

Investigators T. Miko Enomoto, Thomas Johnson MD, Noel Peterson ND, Louis Homer MD, Deb Walts RN, and Nathalie Johnson MD compared 15 patients using RayGel to 15 patients using a placebo. They found that RayGel™ was effective in preventing radiation burn in patients undergoing therapy for breast cancer. Based on these results, a larger 150 patient phase 2 trial is being conducted at 4 Portland area hospitals. For information on enrollment, contact the research nurses at Legacy Good Samaritan Hospital: (503) 413-8199.

Read More Related Articles